Fidelity Investments Portfolio holdings
Fidelity Investments, founded in 1946 by Edward C. Johnson II and headquartered in Boston, Massachusetts, is one of the largest privately-held financial services firms in the world, managing hundreds of billions in assets. Known for its wide array of investment products, including mutual funds, retirement accounts, brokerage services, and wealth management, Fidelity caters to both individual investors and institutions with a reputation for strong customer service and innovative tools like its active trader platforms. The company pioneered direct-to-investor mutual fund sales, bypassing traditional brokers, and has since expanded into areas like cryptocurrency trading and commission-free stock trades. Still family-controlled by the Johnson family, Fidelity blends a legacy of traditional investing with a forward-looking approach to technology and market trends.
Top Buys
| 1 |
Fidelity Investment Grade Securitized ETF
FSEC
|
+$3.9B |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$2.17B |
| 3 |
Amazon
AMZN
|
+$2.13B |
| 4 |
Alibaba
BABA
|
+$2.05B |
| 5 |
Gilead Sciences
GILD
|
+$2.04B |
Top Sells
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$4.21B |
| 2 |
UnitedHealth
UNH
|
+$3.09B |
| 3 |
Apple
AAPL
|
+$3.01B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.02B |
| 5 |
Eli Lilly
LLY
|
+$1.71B |
Sector Composition
| 1 | Technology | 27.9% |
| 2 | Financials | 13.61% |
| 3 | Communication Services | 11.77% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Healthcare | 10.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Brookfield Renewable
BEPC
$6.05B
| $24M | ﹤0.01% |
858,075
-2,421,029
| -74% | -$67.6M |
|
|
NEE.PRS
1602
NextEra Energy, Inc. 7.299% Corporate Units
NEE.PRS
$1.92B
| $23.9M | ﹤0.01% |
496,700
| – | – |
|
1603
Teleflex
TFX
$5.76B
| $23.7M | ﹤0.01% |
171,831
+46,224
| +37% | +$6.39M |
|
1604
Boston Properties
BXP
$11.7B
| $23.7M | ﹤0.01% |
353,253
-380,806
| -52% | -$25.6M |
|
1605
DaVita
DVA
$9.46B
| $23.7M | ﹤0.01% |
155,068
-15,233
| -9% | -$2.33M |
|
1606
Zimmer Biomet
ZBH
$20.7B
| $23.3M | ﹤0.01% |
206,078
-1,231,933
| -86% | -$139M |
|
1607
LXP Industrial Trust 6.5% Series C Cumulative Convertible Preferred Stock
LXP.PRC
$92.5M
| $23.2M | ﹤0.01% |
508,121
| – | – |
|
1608
TPG
TPG
$9.17B
| $23.1M | ﹤0.01% |
487,773
+29,849
| +7% | +$1.42M |
|
1609
Protagonist Therapeutics
PTGX
$3.71B
| $23.1M | ﹤0.01% |
478,343
+35,827
| +8% | +$1.73M |
|
1610
Plumas Bancorp
PLBC
$313M
| $22.9M | ﹤0.01% |
530,057
-25
| -0% | -$1.08K |
|
1611
Hologic
HOLX
$14.6B
| $22.8M | ﹤0.01% |
368,520
-5,206,873
| -93% | -$322M |
|
1612
Broadridge
BR
$29.8B
| $22.6M | ﹤0.01% |
93,079
+7,754
| +9% | +$1.88M |
|
|
KRMN
1613
Karman Holdings Inc.
KRMN
$8.23B
| $22.5M | ﹤0.01% |
+674,693
| New | +$22.5M |
|
|
ZBIO
1614
Zenas BioPharma, Inc. Common Stock
ZBIO
$833M
| $22.5M | ﹤0.01% |
2,852,371
+1,070,656
| +60% | +$8.46M |
|
1615
Alliance Resource Partners
ARLP
$2.89B
| $22.5M | ﹤0.01% |
825,390
+151,800
| +23% | +$4.14M |
|
1616
Dollar General
DG
$23.2B
| $22.3M | ﹤0.01% |
254,021
+125,532
| +98% | +$11M |
|
1617
Iridium Communications
IRDM
$1.95B
| $22.2M | ﹤0.01% |
812,490
-29,848
| -4% | -$815K |
|
1618
Newmark Group
NMRK
$3.4B
| $22.2M | ﹤0.01% |
1,820,900
-2,026,647
| -53% | -$24.7M |
|
1619
Ericsson
ERIC
$26.8B
| $22.2M | ﹤0.01% |
2,855,039
-574,163
| -17% | -$4.46M |
|
1620
RingCentral
RNG
$2.77B
| $22.1M | ﹤0.01% |
893,150
+162,695
| +22% | +$4.03M |
|
1621
Organon & Co
OGN
$2.77B
| $22M | ﹤0.01% |
1,480,330
-147,713
| -9% | -$2.2M |
|
1622
iShares MSCI Intl Momentum Factor ETF
IMTM
$3.3B
| $21.8M | ﹤0.01% |
546,830
-12,106
| -2% | -$484K |
|
1623
Taysha Gene Therapies
TSHA
$887M
| $21.7M | ﹤0.01% |
15,631,954
-733,710
| -4% | -$1.02M |
|
1624
Xoma
XOMA
$442M
| $21.7M | ﹤0.01% |
1,088,370
-1,678
| -0.2% | -$33.4K |
|
1625
Monte Rosa Therapeutics
GLUE
$302M
| $21.7M | ﹤0.01% |
4,674,108
-874,340
| -16% | -$4.06M |
|